{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:22:35Z","timestamp":1791264155615,"version":"4.1.0"},"reference-count":84,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2012,12,31]]},"DOI":"10.18632\/oncotarget.806","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T21:48:09Z","timestamp":1442440089000},"page":"1669-1687","source":"Crossref","is-referenced-by-count":73,"title":["STAT5 triggers<i>BCR-ABL1<\/i>mutation by mediating ROS production in chronic myeloid leukaemia"],"prefix":"10.18632","volume":"3","author":[{"given":"Wolfgang","family":"Warsch","sequence":"first","affiliation":[{"name":"Institute of Pharmacology and Toxicology, Veterinary University Vienna, Veterinaerplatz 1, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Grundschober","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Toxicology, Veterinary University Vienna, Veterinaerplatz 1, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Berger","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Toxicology, Veterinary University Vienna, Veterinaerplatz 1, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gille","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Toxicology, Veterinary University Vienna, Veterinaerplatz 1, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Cerny-Reiterer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna (MUV), Austria"},{"name":"Ludwig Boltzmann Cluster Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Sarmiza","family":"Tigan","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Toxicology, Veterinary University Vienna, Veterinaerplatz 1, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hoelbl-Kovacic","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Toxicology, Veterinary University Vienna, Veterinaerplatz 1, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna (MUV), Austria"},{"name":"Ludwig Boltzmann Cluster Oncology, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moriggl","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute for Cancer Research (LBI-CR), Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Sexl","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Toxicology, Veterinary University Vienna, Veterinaerplatz 1, 1210 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2012,12,31]]},"reference":[{"issue":"3","key":"1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(87)90754-6","article-title":"Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients","volume":"83","author":"Freireich","year":"1987","journal-title":"The American journal of medicine"},{"issue":"5","key":"2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Lydon","year":"1996","journal-title":"Nature medicine"},{"issue":"23","key":"3","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Reiffers","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"24","key":"4","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMe1004430","article-title":"Even better kinase inhibitors for chronic myeloid leukemia","volume":"362","author":"Sawyers","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"10","key":"5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4161\/cc.10.10.15518","article-title":"Explaining the in vitro and in vivo differences in leukemia therapy","volume":"10","author":"Dingli","year":"2011","journal-title":"Cell cycle"},{"issue":"13","key":"6","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","article-title":"Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease","volume":"118","author":"Turhan","year":"2011","journal-title":"Blood"},{"issue":"20","key":"7","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","article-title":"Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment","volume":"118","author":"Bhatia","year":"2011","journal-title":"Blood"},{"issue":"9","key":"8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.18632\/oncotarget.333","article-title":"Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy","volume":"2","author":"Turhan","year":"2011","journal-title":"Oncotarget"},{"issue":"13","key":"9","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"issue":"47","key":"10","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1038\/sj.onc.1206942","article-title":"Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias","volume":"22","author":"Sawyers","year":"2003","journal-title":"Oncogene"},{"issue":"26","key":"11","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1182\/blood-2009-04-219410","article-title":"Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation","volume":"114","author":"Preudhomme","year":"2009","journal-title":"Blood"},{"issue":"5","key":"12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.mrfmmm.2003.06.002","article-title":"The interacting pathways for prevention and repair of oxidative DNA damage","volume":"531","author":"Krokan","year":"2003","journal-title":"Mutation research"},{"key":"14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mrfmmm.2011.02.015","article-title":"Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis","volume":"711","author":"Panayiotidis","year":"2011","journal-title":"Mutation research"},{"issue":"16","key":"15","first-page":"3256","article-title":"Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells","volume":"9","author":"Lisanti","year":"2010","journal-title":"Cell cycle"},{"issue":"6","key":"16","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","article-title":"Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML","volume":"111","author":"Rassool","year":"2008","journal-title":"Blood"},{"issue":"1","key":"17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","article-title":"BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance","volume":"108","author":"Skorski","year":"2006","journal-title":"Blood"},{"issue":"12","key":"18","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2004-05-1941","article-title":"BCR\/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks","volume":"104","author":"Skorski","year":"2004","journal-title":"Blood"},{"issue":"26","key":"19","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.1074\/jbc.M600064200","article-title":"Activated Jak2 with the V617F point mutation promotes G1\/S phase transition","volume":"281","author":"Sattler","year":"2006","journal-title":"The Journal of biological chemistry"},{"issue":"32","key":"20","doi-asserted-by":"crossref","first-page":"24273","DOI":"10.1074\/jbc.M002094200","article-title":"The BCR\/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells","volume":"275","author":"Griffin","year":"2000","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.183.3.811","article-title":"Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr\/Abl","volume":"183","author":"Griffin","year":"1996","journal-title":"The Journal of experimental medicine"},{"issue":"49","key":"22","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","article-title":"P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members","volume":"271","author":"Van Etten","year":"1996","journal-title":"The Journal of biological chemistry"},{"issue":"2","key":"23","first-page":"247","article-title":"Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia","volume":"13","author":"Sawyers","year":"1996","journal-title":"Oncogene"},{"issue":"8","key":"24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.189.8.1229","article-title":"Signal transducer and activator of transcription (STAT)5 activation by BCR\/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR\/ABL and is required for leukemogenesis","volume":"189","author":"Skorski","year":"1999","journal-title":"The Journal of experimental medicine"},{"issue":"8","key":"25","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood-2005-08-3087","article-title":"Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)","volume":"107","author":"Eder","year":"2006","journal-title":"Blood"},{"issue":"12","key":"26","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1182\/blood-2005-10-4110","article-title":"STAT5 signaling is required for the efficient induction and maintenance of CML in mice","volume":"107","author":"Ilaria","year":"2006","journal-title":"Blood"},{"issue":"12","key":"27","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1182\/blood-2005-09-3596","article-title":"Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation","volume":"107","author":"Sexl","year":"2006","journal-title":"Blood"},{"issue":"3","key":"28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","article-title":"Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia","volume":"2","author":"Sexl","year":"2010","journal-title":"EMBO molecular medicine"},{"issue":"4","key":"29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/emmm.201100208","article-title":"Diverging fates of cells of origin in acute and chronic leukaemia","volume":"4","author":"Beug","year":"2012","journal-title":"EMBO molecular medicine"},{"issue":"12","key":"30","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood-2009-10-248211","article-title":"High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia","volume":"117","author":"Sexl","year":"2011","journal-title":"Blood"},{"issue":"9","key":"31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.exphem.2012.05.010","article-title":"Phosphoprotein profiling predicts response to tyrosine kinase inhibitor therapy in chronic myeloid leukemia patients","volume":"40","author":"Mustjoki","year":"2012","journal-title":"Experimental hematology"},{"issue":"3","key":"32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.07.030","article-title":"The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia","volume":"16","author":"Lieber","year":"2009","journal-title":"Cancer cell"},{"issue":"4","key":"33","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2010-09-307256","article-title":"Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia","volume":"118","author":"Skorski","year":"2011","journal-title":"Blood"},{"issue":"4","key":"34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1097-2765(01)00357-4","article-title":"BCR\/ABL regulates mammalian RecA homologs, resulting in drug resistance","volume":"8","author":"Skorski","year":"2001","journal-title":"Molecular cell"},{"key":"35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1749-6632.2010.05192.x","article-title":"Transcriptome analysis and tumor suppressor requirements of STAT5-induced senescence","volume":"1197","author":"Ferbeyre","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"15","key":"36","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.4161\/cc.6.15.4516","article-title":"The DNA damage signaling pathway connects oncogenic stress to cellular senescence","volume":"6","author":"Ferbeyre","year":"2007","journal-title":"Cell Cycle"},{"issue":"2","key":"37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/BJ20060623","article-title":"STAT5 proteins are involved in down-regulation of iron regulatory protein 1 gene expression by nitric oxide","volume":"400","author":"Lipinski","year":"2006","journal-title":"The Biochemical journal"},{"issue":"9","key":"38","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1182\/blood-2008-02-138339","article-title":"Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1","volume":"112","author":"Mullner","year":"2008","journal-title":"Blood"},{"issue":"27","key":"39","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1073\/pnas.0400593101","article-title":"Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity","volume":"101","author":"Fukamizu","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"44","key":"40","doi-asserted-by":"crossref","first-page":"29730","DOI":"10.1074\/jbc.M805514200","article-title":"Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase","volume":"283","author":"Li","year":"2008","journal-title":"The Journal of biological chemistry"},{"issue":"9","key":"41","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2009-12-258913","article-title":"Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation","volume":"116","author":"Moriggl","year":"2010","journal-title":"Blood"},{"issue":"1","key":"42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccr.2004.12.010","article-title":"Stat5 tetramer formation is associated with leukemogenesis","volume":"7","author":"Beug","year":"2005","journal-title":"Cancer cell"},{"issue":"3","key":"43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/emboj\/19.3.392","article-title":"A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5","volume":"19","author":"Ihle","year":"2000","journal-title":"The EMBO journal"},{"issue":"7","key":"44","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/blood-2009-07-234963","article-title":"STAT5 requires the N-domain for suppression of miR15\/16, induction of bcl-2, and survival signaling in myeloproliferative disease","volume":"115","author":"Bunting","year":"2010","journal-title":"Blood"},{"issue":"3","key":"45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nchembio.775","article-title":"BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia","volume":"8","author":"Sexl","year":"2012","journal-title":"Nat Chem Biol"},{"issue":"14","key":"46","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/onc.2009.7","article-title":"Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients","volume":"28","author":"Arlinghaus","year":"2009","journal-title":"Oncogene"},{"issue":"3","key":"47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/leu.2010.287","article-title":"Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia","volume":"25","author":"Arlinghaus","year":"2011","journal-title":"Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"issue":"15","key":"48","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Shepard","year":"2010","journal-title":"Blood"},{"issue":"7","key":"49","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Druker","year":"2005","journal-title":"Blood"},{"issue":"5","key":"50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/mcbr.2000.0231","article-title":"STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells","volume":"3","author":"Koenderman","year":"2000","journal-title":"Molecular cell biology research communications : MCBRC"},{"issue":"6","key":"51","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.191.6.977","article-title":"Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL","volume":"191","author":"Fernandez-Luna","year":"2000","journal-title":"The Journal of experimental medicine"},{"issue":"6","key":"52","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V96.6.2269","article-title":"Bcr\/Abl activates transcription of the Bcl-X gene through STAT5","volume":"96","author":"Griffin","year":"2000","journal-title":"Blood"},{"issue":"8","key":"53","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides","volume":"105","author":"Sillaber","year":"2005","journal-title":"Blood"},{"issue":"2","key":"54","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4161\/cc.10.2.14537","article-title":"Impact of BCR-ABL mutations on patients with chronic myeloid leukemia","volume":"10","author":"Cross","year":"2011","journal-title":"Cell cycle"},{"issue":"5","key":"55","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood-2010-12-326405","article-title":"BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet","volume":"118","author":"Martinelli","year":"2011","journal-title":"Blood"},{"issue":"1","key":"56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2005.01.089","article-title":"Identification of novel Nox4 splice variants with impact on ROS levels in A549 cells","volume":"329","author":"Hanze","year":"2005","journal-title":"Biochemical and biophysical research communications"},{"issue":"19","key":"57","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1016\/S0021-9258(17)37968-1","article-title":"Solubilization of the O2(-)-forming activity responsible for the respiratory burst in human neutrophils","volume":"253","author":"Babior","year":"1978","journal-title":"The Journal of biological chemistry"},{"issue":"4 Pt 1","key":"58","first-page":"C961","article-title":"Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes","volume":"264","author":"Lemasters","year":"1993","journal-title":"The American journal of physiology"},{"issue":"3","key":"59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/ars.1999.1.3-371","article-title":"The thermodynamics of xanthine oxidoreductase catalysis","volume":"1","author":"Massey","year":"1999","journal-title":"Antioxidants & redox signaling"},{"issue":"22","key":"60","doi-asserted-by":"crossref","first-page":"16899","DOI":"10.1074\/jbc.M000301200","article-title":"Superoxide production and reactive oxygen species signaling by endothelial nitric-oxide synthase","volume":"275","author":"Danner","year":"2000","journal-title":"The Journal of biological chemistry"},{"issue":"13","key":"61","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJM197803302981305","article-title":"Oxygen-dependent microbial killing by phagocytes (second of two parts)","volume":"298","author":"Babior","year":"1978","journal-title":"The New England journal of medicine"},{"issue":"3","key":"62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0034-5687(01)00310-3","article-title":"Tissue oxygen sensor function of NADPH oxidase isoforms, an unusual cytochrome aa3 and reactive oxygen species","volume":"128","author":"Acker","year":"2001","journal-title":"Respiration physiology"},{"issue":"2","key":"63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0034-5687(99)00023-7","article-title":"Roles for NAD(P)H oxidases and reactive oxygen species in vascular oxygen sensing mechanisms","volume":"115","author":"Mohazzab","year":"1999","journal-title":"Respiration physiology"},{"issue":"6","key":"64","doi-asserted-by":"crossref","first-page":"L1005","DOI":"10.1152\/ajplung.2000.279.6.L1005","article-title":"Reactive oxygen species in cell signaling","volume":"279","author":"Fanburg","year":"2000","journal-title":"American journal of physiology Lung cellular and molecular physiology"},{"issue":"12","key":"65","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1074\/jbc.M008471200","article-title":"Nitric oxide disrupts H2O2-dependent activation of nuclear factor kappa B. Role in sensitization of human tumor cells to tumor necrosis factor-alpha -induced cytotoxicity","volume":"276","author":"Bonavida","year":"2001","journal-title":"The Journal of biological chemistry"},{"issue":"19","key":"66","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4161\/cc.9.19.13324","article-title":"Activation of senescence and aging characteristics by mitochondrially generated ROS: how are they linked?","volume":"9","author":"Hsieh","year":"2010","journal-title":"Cell cycle"},{"issue":"10","key":"67","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.freeradbiomed.2004.02.071","article-title":"Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species","volume":"36","author":"Hanze","year":"2004","journal-title":"Free radical biology & medicine"},{"issue":"33","key":"68","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing","volume":"275","author":"Schumacker","year":"2000","journal-title":"The Journal of biological chemistry"},{"issue":"12","key":"69","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1182\/blood-2010-08-303669","article-title":"Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells","volume":"117","author":"Schuringa","year":"2011","journal-title":"Blood"},{"issue":"6","key":"70","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1172\/JCI116491","article-title":"Hypercholesterolemia increases endothelial superoxide anion production","volume":"91","author":"Harrison","year":"1993","journal-title":"The Journal of clinical investigation"},{"issue":"2 Pt 2","key":"71","first-page":"H321","article-title":"Free radicals mediate endothelial cell dysfunction caused by elevated glucose","volume":"263","author":"Cohen","year":"1992","journal-title":"The American journal of physiology"},{"issue":"3","key":"72","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.95.3.588","article-title":"Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension","volume":"95","author":"Harrison","year":"1997","journal-title":"Circulation"},{"issue":"6748","key":"73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/43459","article-title":"Cell transformation by the superoxide-generating oxidase Mox1","volume":"401","author":"Lambeth","year":"1999","journal-title":"Nature"},{"issue":"18","key":"74","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","article-title":"Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors","volume":"119","author":"Valent","year":"2012","journal-title":"Blood"},{"issue":"6","key":"75","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/hep.25900","article-title":"The liver-specific tumor suppressor STAT5 controls expression of the reactive oxygen species-generating enzyme NOX4 and the proapoptotic proteins PUMA and BIM in mice","volume":"56","author":"Hennighausen","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"76","first-page":"104","article-title":"The role of Stat5 transcription factors as tumor suppressors or oncogenes","volume":"1815","author":"Moriggl","year":"2011","journal-title":"Biochimica et biophysica acta"},{"issue":"10","key":"77","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1128\/MCB.16.10.5691","article-title":"Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype","volume":"16","author":"Gouilleux","year":"1996","journal-title":"Mol Cell Biol"},{"issue":"4","key":"78","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/MCB.16.4.1622","article-title":"Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response","volume":"16","author":"Ihle","year":"1996","journal-title":"Molecular and cellular biology"},{"issue":"9","key":"79","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1182\/blood-2007-07-102848","article-title":"Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2","volume":"111","author":"Moriggl","year":"2008","journal-title":"Blood"},{"issue":"3","key":"80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni1172","article-title":"STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression","volume":"6","author":"Spits","year":"2005","journal-title":"Nat Immunol"},{"issue":"4","key":"81","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood-2006-11-055723","article-title":"Targeting of heat shock protein 32 (Hsp32)\/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib","volume":"111","author":"Sillaber","year":"2008","journal-title":"Blood"},{"issue":"1","key":"82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2007.05.019","article-title":"Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function","volume":"27","author":"Busslinger","year":"2007","journal-title":"Immunity"},{"issue":"4","key":"83","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.immuni.2009.01.012","article-title":"Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis","volume":"30","author":"Busslinger","year":"2009","journal-title":"Immunity"},{"issue":"11","key":"84","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1093\/nar\/gkn271","article-title":"In vivo identification of novel STAT5 target genes","volume":"36","author":"Rascle","year":"2008","journal-title":"Nucleic acids research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.806","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T23:21:46Z","timestamp":1653175306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,31]]},"references-count":84,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["806","23458731"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.806","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,31]]}}}